<DOC>
	<DOC>NCT02958865</DOC>
	<brief_summary>The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.</brief_summary>
	<brief_title>Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Diagnosis of ulcerative colitis for greater than/equal to 4 months. Moderate to severe active ulcerative colitis Inadequate response to, loss of response to, or intolerance to at least one conventional therapy for UC. Pregnant or breastfeeding Clinical findings suggestive of Crohn's Disease History of bowel surgery within 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Mayo score</keyword>
</DOC>